Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $27.2 million versus the consensus estimate of $28.22 million.

GUIDANCE:

Aspen Aerogels sees FY2017 EPS of ($0.82)-($0.90). Aspen Aerogels sees FY2017 revenue of $106-112 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.